Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Our business principally involves the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using our proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. We also manufacture and sell medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Our diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.22 |
| Quarterly EPS Est: | -0.16 |
| PEG Ratio: | -.54 |
|
Mean Recommendation: View Summary / View All |
1.5 |
Data is provided by Zacks Investment Research

